Drug Reference
Zalcitabine
Nucleoside and nucleotide reverse transcriptase inhibitors
Fact box
- Therapeutic class
- Nucleoside and nucleotide reverse transcriptase inhibitors
- Habit forming
- No
Available as
0.375 MG · Oral Tablet0.75 MG · Oral Tablet
No structured FDA label was available. Use the authoritative links below.
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.